Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway
Min Zhao,1 Liuxiang Feng,2 Wenhua Li3 1School of Medicine, Lijiang University of Culture and Tourism, Lijiang, Yunnan, 674100, People's Republic of China; 2People's Hospital of Yulong Naxi Autonomous County of Lijiang City, Lijiang, Yunnan, 674112, People's Republic of China; 3School...
Saved in:
Main Authors: | Zhao M (Author), Feng L (Author), Li W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ren-Shen-Bu-Qi decoction alleviates exercise fatigue through activating PI3K/AKT/Nrf2 pathway in mice
by: Yangyang Chen, et al.
Published: (2024) -
Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
by: Zhang S, et al.
Published: (2021) -
Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial-Mesenchymal Transition
by: Yuan Zhao, et al.
Published: (2022) -
An Integrated Approach Based on Network Analysis Combined With Experimental Verification Reveals PI3K/Akt/Nrf2 Signaling Is an Important Way for the Anti-Myocardial Ischemia Activity of Yi-Qi-Tong-Luo Capsule
by: Huxinyue Duan, et al.
Published: (2022) -
Network pharmacology approach and experimental verification of Dan-Shen Decoction in the treatment of ischemic heart disease
by: Difei Gong, et al.
Published: (2023)